"Chikungunya virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of ALPHAVIRUS causing an acute dengue-like fever.
| Descriptor ID |
D002646
|
| MeSH Number(s) |
B04.820.850.054.198
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chikungunya virus".
Below are MeSH descriptors whose meaning is more specific than "Chikungunya virus".
This graph shows the total number of publications written about "Chikungunya virus" by people in this website by year, and whether "Chikungunya virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 2 | 4 |
| 2023 | 2 | 0 | 2 |
| 2025 | 2 | 0 | 2 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chikungunya virus" by people in Profiles.
-
Investigating antibody cross-reactivity and transmission dynamics of alphaviruses and flaviviruses using a multiplex serological assay. Nat Commun. 2026 Apr 15; 17(1).
-
Epidemiological and genomic features of chikungunya virus disease in travellers returning from Cuba, September 2025 to January 2026:?a GeoSentinel analysis. Euro Surveill. 2026 Apr; 31(16).
-
A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults. J Infect Dis. 2026 Mar 17; 233(3):e641-e645.
-
Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis. Reprod Health. 2025 Apr 18; 22(1):56.
-
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines. Hum Vaccin Immunother. 2025 Dec; 21(1):2463191.
-
Developing a Prototype Pathogen Plan and Research Priorities for the Alphaviruses. J Infect Dis. 2023 10 18; 228(Suppl 6):S414-S426.
-
A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans. Sci Transl Med. 2023 05 17; 15(696):eade8273.
-
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat Med. 2021 12; 27(12):2224-2233.
-
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 2021 08 19; 184(17):4430-4446.e22.
-
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope. Cell. 2021 08 19; 184(17):4414-4429.e19.